| |
Company
Roster
|
|
Total
Insiders : |
16 |
|
|
|
Total
Direct Shares :
|
9,819,412 |
|
|
Total
Indirect Shares :
|
11,793,519 |
| |
%
Held by Insiders:
|
19.74% |
|
|
| |
| Filer's Name |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
  Rogers Bruce |
|
2024-03-27 |
149,883 |
|
0 |
| Schegerin Marc |
CFO and COO |
2024-01-16 |
37,460 |
|
0 |
| Farrell Robert E Jr |
SVP Finance and CAO |
2024-01-16 |
34,992 |
|
0 |
| Tipirneni Praveen P. |
CEO, Director |
2024-01-16 |
42,013 |
2021-02-02 |
614,474 |
| Devaul William |
General Counsel and Secretary |
2024-01-16 |
23,029 |
2020-07-01 |
0 |
| Edwards Martin |
Director |
2023-11-13 |
2,376 |
2023-11-13 |
0 |
| Slattery Joseph P |
Director |
2023-11-13 |
9,066 |
2019-07-01 |
0 |
| Nashat Amir |
Director |
2023-06-28 |
145 |
2023-06-28 |
130,153 |
| Springer Timothy A |
Director, 10% Owner |
2023-06-28 |
4,608,052 |
2023-06-28 |
2,811,766 |
| Linde Peter |
Chief Medical Officer |
2021-09-16 |
11,272 |
2021-03-16 |
0 |
| Stampacchia Otello |
Director |
2021-04-30 |
2,068,913 |
2019-07-01 |
2,969,582 |
| Goyal Vikas |
Director |
2021-03-05 |
1,000 |
2019-07-01 |
2,633,772 |
| Lugovskoy Alexey |
Chief Development Officer |
2020-11-10 |
85,248 |
|
0 |
| Glaxosmithkline Plc |
Director |
2019-07-01 |
0 |
2019-07-01 |
2,633,772 |
| Christensen Gustav |
Director |
2019-07-01 |
100,517 |
|
0 |
| Novo A/s |
10% Owner |
2019-06-28 |
2,645,446 |
2019-06-28 |
0 |
|
|
0.09 (0.32%) 
